Inhibition of voltage-dependent K+ channels in rabbit coronary arterial smooth muscle cells by the atypical antipsychotic agent sertindole

J Appl Toxicol. 2024 Mar;44(3):391-399. doi: 10.1002/jat.4549. Epub 2023 Oct 3.

Abstract

The regulation of membrane potential and the contractility of vascular smooth muscle cells (VSMCs) by voltage-dependent K+ (Kv) potassium channels are well-established. In this study, native VSMCs from rabbit coronary arteries were used to investigate the inhibitory effect of sertindole, an atypical antipsychotic agent, on Kv channels. Sertindole induced dose-dependent inhibition of Kv channels, with an IC50 of 3.13 ± 0.72 μM. Although sertindole did not cause a change in the steady-state activation curve, it did lead to a negative shift in the steady-state inactivation curve. The application of 1- or 2-Hz train pulses failed to alter the sertindole-induced inhibition of Kv channels, suggesting use-independent effects of the drug. The inhibitory response to sertindole was significantly diminished by pretreatment with a Kv1.5 inhibitor but not by Kv2.1 and Kv7 subtype inhibitors. These findings demonstrate the sertindole dose-dependent and use-independent inhibition of vascular Kv channels (mainly the Kv1.5 subtype) through a mechanism that involves altering steady-state inactivation curves. Therefore, the use of sertindole as an antipsychotic drug may have adverse effects on the cardiovascular system.

Keywords: coronary arterial smooth muscle cell; electrophysiology; sertindole; voltage-dependent K+ channel.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipsychotic Agents* / toxicity
  • Coronary Vessels
  • Imidazoles*
  • Indoles*
  • Myocytes, Smooth Muscle
  • Potassium Channel Blockers / toxicity
  • Potassium Channels, Voltage-Gated* / pharmacology
  • Rabbits

Substances

  • Antipsychotic Agents
  • sertindole
  • Potassium Channels, Voltage-Gated
  • Potassium Channel Blockers
  • Imidazoles
  • Indoles